China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 1.94
(0.0%)
HKD 1.94
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.28 Billion CNY | 68.11% |
| 2022 | 764.48 Million CNY | -60.45% |
| 2021 | 1.93 Billion CNY | 16.21% |
| 2020 | 1.66 Billion CNY | 4.73% |
| 2019 | 1.58 Billion CNY | 10.36% |
| 2018 | 1.43 Billion CNY | 22.95% |
| 2017 | 1.17 Billion CNY | 21.05% |
| 2016 | 966.92 Million CNY | 55.53% |
| 2015 | 621.69 Million CNY | 50.5% |
| 2014 | 413.09 Million CNY | 108.14% |
| 2013 | 198.46 Million CNY | 18.99% |
| 2012 | 166.78 Million CNY | 185.93% |
| 2011 | 58.32 Million CNY | 12.34% |
| 2010 | 51.92 Million CNY | 33.86% |
| 2009 | 38.78 Million CNY | 116.68% |
| 2008 | 17.9 Million CNY | -23.67% |
| 2007 | 23.45 Million CNY | 105.42% |
| 2006 | -432.85 Million CNY | 48.48% |
| 2005 | -840.2 Million CNY | -1311.87% |
| 2004 | -59.5 Million CNY | -217.65% |
| 2003 | -18.73 Million CNY | -135.6% |
| 2002 | 52.61 Million CNY | 285.11% |
| 2001 | 13.66 Million CNY | 165.84% |
| 2000 | -20.75 Million CNY | -120.34% |
| 1999 | 102 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 105.48 Million CNY | -70.14% |
| 2024 Q2 | 105.48 Million CNY | 0.0% |
| 2023 Q1 | 289.37 Million CNY | 64.93% |
| 2023 Q3 | 353.22 Million CNY | 22.07% |
| 2023 FY | 1.28 Billion CNY | 68.11% |
| 2023 Q4 | 353.22 Million CNY | 0.0% |
| 2023 Q2 | 289.37 Million CNY | 0.0% |
| 2022 Q2 | 206.79 Million CNY | 0.0% |
| 2022 Q1 | 206.79 Million CNY | -58.77% |
| 2022 FY | 764.48 Million CNY | -60.45% |
| 2022 Q4 | 175.44 Million CNY | 0.0% |
| 2022 Q3 | 175.44 Million CNY | -15.16% |
| 2021 Q3 | 501.51 Million CNY | 7.87% |
| 2021 Q4 | 501.51 Million CNY | 0.0% |
| 2021 FY | 1.93 Billion CNY | 16.21% |
| 2021 Q1 | 464.91 Million CNY | -0.15% |
| 2021 Q2 | 464.91 Million CNY | 0.0% |
| 2020 FY | 1.66 Billion CNY | 4.73% |
| 2020 Q3 | 465.61 Million CNY | 27.21% |
| 2020 Q2 | 366.01 Million CNY | 0.0% |
| 2020 Q4 | 465.61 Million CNY | 0.0% |
| 2020 Q1 | 366.01 Million CNY | 0.42% |
| 2019 Q4 | 364.49 Million CNY | 0.0% |
| 2019 Q2 | 429.56 Million CNY | 0.0% |
| 2019 Q1 | 429.56 Million CNY | 26.58% |
| 2019 FY | 1.58 Billion CNY | 10.36% |
| 2019 Q3 | 364.49 Million CNY | -15.15% |
| 2018 Q4 | 339.35 Million CNY | 0.0% |
| 2018 FY | 1.43 Billion CNY | 22.95% |
| 2018 Q3 | 339.35 Million CNY | -10.73% |
| 2018 Q2 | 380.15 Million CNY | 0.0% |
| 2018 Q1 | 380.15 Million CNY | 32.97% |
| 2017 FY | 1.17 Billion CNY | 21.05% |
| 2017 Q4 | 285.9 Million CNY | 0.0% |
| 2017 Q1 | 299.31 Million CNY | 25.72% |
| 2017 Q3 | 285.9 Million CNY | -4.48% |
| 2017 Q2 | 299.31 Million CNY | 0.0% |
| 2016 Q1 | 245.38 Million CNY | 62.11% |
| 2016 FY | 966.92 Million CNY | 55.53% |
| 2016 Q4 | 238.07 Million CNY | 0.0% |
| 2016 Q3 | 238.07 Million CNY | -2.98% |
| 2016 Q2 | 245.38 Million CNY | 0.0% |
| 2015 Q4 | 151.37 Million CNY | 0.0% |
| 2015 Q1 | 121.62 Million CNY | 6.71% |
| 2015 FY | 621.69 Million CNY | 50.5% |
| 2015 Q2 | 121.62 Million CNY | 0.0% |
| 2015 Q3 | 151.37 Million CNY | 24.46% |
| 2014 Q4 | 113.97 Million CNY | 0.0% |
| 2014 FY | 413.09 Million CNY | 108.14% |
| 2014 Q3 | 113.97 Million CNY | 20.74% |
| 2014 Q2 | 94.39 Million CNY | 0.0% |
| 2014 Q1 | 94.39 Million CNY | 39.41% |
| 2013 Q2 | 31.51 Million CNY | 0.0% |
| 2013 Q4 | 67.71 Million CNY | 0.0% |
| 2013 Q3 | 67.71 Million CNY | 114.84% |
| 2013 FY | 198.46 Million CNY | 18.99% |
| 2013 Q1 | 31.51 Million CNY | -40.43% |
| 2012 Q1 | 42.8 Million CNY | 0.0% |
| 2012 Q2 | 42.8 Million CNY | 0.0% |
| 2012 Q3 | 52.65 Million CNY | 23.0% |
| 2012 Q4 | 52.91 Million CNY | 0.49% |
| 2012 FY | 166.78 Million CNY | 185.93% |
| 2011 Q1 | 14.91 Million CNY | 0.0% |
| 2011 FY | 58.32 Million CNY | 12.34% |
| 2011 Q4 | 42.8 Million CNY | 187.03% |
| 2011 Q3 | 14.91 Million CNY | 0.0% |
| 2011 Q2 | 14.91 Million CNY | 0.0% |
| 2010 Q4 | 14.91 Million CNY | -18.68% |
| 2010 FY | 51.92 Million CNY | 33.86% |
| 2010 Q3 | 18.33 Million CNY | 0.0% |
| 2010 Q1 | 18.33 Million CNY | 0.0% |
| 2010 Q2 | 18.33 Million CNY | 0.0% |
| 2009 Q3 | 15.01 Million CNY | 0.0% |
| 2009 Q1 | 15.01 Million CNY | 0.0% |
| 2009 Q2 | 15.01 Million CNY | 0.0% |
| 2009 Q4 | 18.33 Million CNY | 22.12% |
| 2009 FY | 38.78 Million CNY | 116.68% |
| 2008 Q1 | 10.66 Million CNY | 0.0% |
| 2008 FY | 17.9 Million CNY | -23.67% |
| 2008 Q4 | 15.01 Million CNY | 40.76% |
| 2008 Q3 | 10.66 Million CNY | 0.0% |
| 2008 Q2 | 10.66 Million CNY | 0.0% |
| 2007 Q3 | 5.86 Million CNY | 0.0% |
| 2007 Q4 | 10.66 Million CNY | 81.96% |
| 2007 FY | 23.45 Million CNY | 105.42% |
| 2007 Q1 | 5.86 Million CNY | 0.0% |
| 2007 Q2 | 5.86 Million CNY | 0.0% |
| 2006 Q1 | -1.6 Million CNY | 0.0% |
| 2006 FY | -432.85 Million CNY | 48.48% |
| 2006 Q4 | 5.86 Million CNY | 465.98% |
| 2006 Q3 | -1.6 Million CNY | 0.0% |
| 2006 Q2 | -1.6 Million CNY | 0.0% |
| 2005 Q2 | -210.05 Million CNY | 0.0% |
| 2005 Q4 | -1.6 Million CNY | 99.24% |
| 2005 Q3 | -210.05 Million CNY | 0.0% |
| 2005 Q1 | -210.05 Million CNY | 0.0% |
| 2005 FY | -840.2 Million CNY | -1311.87% |
| 2004 Q2 | -16.1 Million CNY | 0.0% |
| 2004 Q3 | -16.1 Million CNY | 0.0% |
| 2004 Q4 | -210.05 Million CNY | -1204.15% |
| 2004 FY | -59.5 Million CNY | -217.65% |
| 2004 Q1 | -16.1 Million CNY | 0.0% |
| 2003 Q1 | -3.37 Million CNY | 0.0% |
| 2003 FY | -18.73 Million CNY | -135.6% |
| 2003 Q4 | -16.1 Million CNY | -376.64% |
| 2003 Q2 | -3.37 Million CNY | 0.0% |
| 2003 Q3 | -3.37 Million CNY | 0.0% |
| 2002 Q2 | 18.91 Million CNY | 0.0% |
| 2002 Q3 | 18.91 Million CNY | 0.0% |
| 2002 FY | 52.61 Million CNY | 285.11% |
| 2002 Q4 | -3.37 Million CNY | -117.86% |
| 2002 Q1 | 18.91 Million CNY | 0.0% |
| 2001 Q2 | 6.67 Million CNY | 0.0% |
| 2001 Q1 | 6.67 Million CNY | 0.0% |
| 2001 FY | 13.66 Million CNY | 165.84% |
| 2001 Q4 | 18.91 Million CNY | 183.33% |
| 2001 Q3 | 6.67 Million CNY | 0.0% |
| 2000 Q2 | -4.06 Million CNY | 0.0% |
| 2000 Q1 | -4.06 Million CNY | 0.0% |
| 2000 FY | -20.75 Million CNY | -120.34% |
| 2000 Q4 | 6.67 Million CNY | 264.23% |
| 2000 Q3 | -4.06 Million CNY | 0.0% |
| 1999 Q2 | 34.49 Million CNY | 0.0% |
| 1999 Q3 | 34.49 Million CNY | 0.0% |
| 1999 Q4 | -4.06 Million CNY | -111.79% |
| 1999 FY | 102 Million CNY | 0.0% |
| 1999 Q1 | 34.49 Million CNY | 0.0% |
| 1998 Q4 | 34.49 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | -1123.546% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | 31.638% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 888.713% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 8469.367% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 2538.478% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | -7596.73% |
| Essex Bio-Technology Limited | 275.25 Million HKD | -366.905% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 4555.847% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 1311.527% |
| SSY Group Limited | 1.31 Billion HKD | 2.534% |
| JBM (Healthcare) Limited | 130.46 Million HKD | -885.107% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | -381.406% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 66.655% |